<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39">
 <label>39.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Smith</surname>
    <given-names>NJ</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ward</surname>
    <given-names>RJ</given-names>
   </name>, 
   <name name-style="western">
    <surname>Stoddart</surname>
    <given-names>LA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Hudson</surname>
    <given-names>BD</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kostenis</surname>
    <given-names>E</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ulven</surname>
    <given-names>T</given-names>
   </name>, 
   <name name-style="western">
    <surname>Morris</surname>
    <given-names>JC</given-names>
   </name>, 
   <name name-style="western">
    <surname>Trankle</surname>
    <given-names>C</given-names>
   </name>, 
   <name name-style="western">
    <surname>Tikhonova</surname>
    <given-names>IG</given-names>
   </name>, 
   <name name-style="western">
    <surname>Adams</surname>
    <given-names>DR</given-names>
   </name>, 
   <name name-style="western">
    <surname>Milligan</surname>
    <given-names>G</given-names>
   </name>
  </person-group>
  <year>2011</year>
  <article-title>Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator</article-title>. 
  <source>Mol Pharmacol</source>
  <volume>80</volume>:
  <fpage>163</fpage>â€“
  <lpage>173</lpage>. doi:
  <pub-id pub-id-type="doi">10.1124/mol.110.070789</pub-id>.
  <pub-id pub-id-type="pmid">21498659</pub-id>
 </mixed-citation>
</ref>
